Pharma
The term pharma is a shortened version of the word pharmaceutical, which can be used to describe medication, its manufacturers, or the associated industry. Pharma is also used as a shortened version of pharmacology, which describes the biomedical science behind pharmaceuticals and their effects on the body.
What Are Pharmaceuticals?
Pharmaceuticals refer to drugs and medications that are used to diagnose, treat, or prevent diseases. These compounds can be derived from natural sources or synthesized in laboratories. Pharmaceuticals are critical in managing health conditions, curing diseases, and promoting overall health and wellness.
Regulation of Pharmaceuticals in the United States
In the United States, the regulation of pharmaceuticals is primarily handled by the Food and Drug Administration (FDA). The FDA ensures that all pharmaceuticals sold in the U.S. meet these critical requirements:
- Safety: Before any new drug can be sold, it must be proven safe through rigorous laboratory testing and clinical trials.
- Efficacy: Pharmaceuticals must demonstrate effectiveness in treating the conditions for which they are marketed.
- Quality: Drugs must be consistent in strength, purity, and quality. This standard is maintained through strict manufacturing oversight and compliance checks.
The FDA’s drug approval process involves several stages, including:
- Preclinical Research: Testing of drugs on animals to assess safety and biological activity.
- Clinical Trials: Drug testing in humans, which occurs in phases to evaluate safety, effectiveness, optimal dosages, and side effects.
- Review and Approval: Submission of a New Drug Application (NDA) containing all testing data for FDA review; if the benefits outweigh the risks, the drug is approved for sale.
International Regulation of Pharmaceuticals
Internationally, the regulation of pharmaceuticals varies by country but generally follows principles similar to those of the FDA. Several international bodies help harmonize regulations across countries:
European Medicines Agency (EMA): Regulates drugs within the European Union, ensuring safety, efficacy, and quality.
World Health Organization (WHO): Provides guidelines and standards to improve healthcare worldwide, including the regulation of pharmaceuticals.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): Brings together regulatory authorities and pharmaceutical industry representatives from multiple regions to discuss scientific and technical aspects of drug registration.
Challenges and Considerations
Regulating pharmaceuticals involves addressing numerous challenges, such as the rise of counterfeit drugs, ethical concerns in drug testing, and the need for expedited approvals for life-saving treatments without compromising safety. Global collaboration and continual improvement in regulatory frameworks are essential to meet these challenges effectively.
Overall, the regulation of pharmaceuticals is a complex but vital component of global healthcare, ensuring that all medications available to the public are safe, effective, and of the highest quality.
Medical Devices and Pharma
Medical Devices and Pharma provides the latest agency information for drug shortages, alerts, and recalls. We also publish information about pharma product innovations and enforcement actions like FDA warning letters to pharma manufacturers. And of course, we cover other news from FDA and global news sources.
Pharma Headlines
FDA Program to Accelerate U.S. Pharmaceutical Manufacturing
FDA Launches “PreCheck” Pilot Program to Accelerate U.S. Pharmaceutical Manufacturing The U.S. Food and Drug Administration has launched a new pilot initiative aimed at strengthening domestic pharmaceutical manufacturing and improving regulatory predictability for...
FDA Issues 30 Warning Letters to Telehealth Firms
FDA Issues 30 Warning Letters to Telehealth Firms Over Compounded GLP-1 Marketing Claims On March 3, 2026, the U.S. Food and Drug Administration (FDA) announced that it has issued 30 warning letters to telehealth companies for making false or misleading claims...
FDA Warning Letter Cites Key CGMP and Data Integrity Failures
FDA Warning Letter Highlights Fundamental CGMP and Data Integrity Failures The FDA has issued a Warning Letter to A. Nelson & Co. Ltd. citing significant violations of Current Good Manufacturing Practice (CGMP) requirements under 21 CFR Parts 210 and 211 at a...
FDA Approves First Generic Fenbendazole Oral Suspension
Defendazole™ (fenbendazole) 10% Oral Suspension The U.S. Food and Drug Administration has approved Defendazole™ (fenbendazole) 10% oral suspension, the first FDA-approved generic fenbendazole dewormer for use in beef and dairy cattle and goats. Defendazole is...
FDA Testosterone Panel Sparks Concern
Concerns Over Sudden Regulatory Shift The FDA’s December 2025 expert panel has recommended sweeping changes to testosterone regulation – a sharp departure from the agency’s long-standing cautionary stance for the hormone. The panel urged the FDA to broaden...
Testosterone Regulation Takes a Sharp Turn
Why FDA’s December Panel Raises Red Flags Regulatory Analysis The FDA’s regulation of testosterone therapy has long been a model of cautious, evidence-based policymaking. For more than a decade, the agency maintained a consistent position: testosterone was approved...
FDA “PreCheck” Program to Boost U.S. Drug Manufacturing
FDA Announces New PreCheck Drug Manufacturing Program The U.S. Food and Drug Administration (FDA) has announced the launch of FDA PreCheck, a groundbreaking new program designed to strengthen America’s domestic pharmaceutical supply chain by streamlining the...
FDA Cracks Down on Illegally Marketed 7-OH Products
Unapproved drugs sold online and in retail locations Yesterday the U.S. Food and Drug Administration (FDA) issued seven warning letters to companies marketing products that contain 7-hydroxymitragynine (7-OH) — a powerful and potentially dangerous opioid-like...
Sterile Drug Manufacturing Violations at Daewoo Pharmaceutical
FDA Cracks Down on Sterile Drug Manufacturing Violations The U.S. Food and Drug Administration (FDA) has issued a warning letter to Daewoo Pharmaceutical Co., Ltd. in Busan, South Korea, citing serious and widespread violations of current Good Manufacturing Practices...
The FDA Orphan Drug Program
Incentives for Rare Disease Drug Development The FDA’s Orphan Drug Program was established to encourage the development of drugs for rare diseases that affect fewer than 200,000 people in the U.S. Because these diseases often lack market incentives due to small...